The Remdesivir Global Market Report
2020-30 by The Business Research Company describes and explains the global remdesivir
market and covers 2015 to 2020, termed the historic period, and 2020 to 2025,
termed the forecast period, along with further forecasts for the period
2025-2030. The report evaluates the market across each region and for the major
economies within each region.
The Remdesivir Global Market Report
2021 covers remdesivir market drivers, remdesivir market trends, remdesivir
market segments, remdesivir market growth rate, remdesivir market major
players, and remdesivir market size.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/remdesivir-market-global-report-2020-30-covid-19-growth-and-change
The remdesivir market report provides
an in-depth analysis of the impact of COVID-19 on the global remdesivir
industry, along with revised market numbers due to the effects of the
coronavirus and the expected remdesivir market growth numbers 2021-2030.
Remdesivir Global Market Report 2021 is the
most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
Request
For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp
The global remdesivir market is expected to grow from $1.98
billion in 2020 to $2.55 billion in 2021 at a compound annual growth rate
(CAGR) of 28.8%. The growth is mainly due to the companies resuming their
operations and adapting to the new normal while recovering from the COVID-19
impact, which had earlier led to restrictive containment measures involving
social distancing, remote working, and the closure of commercial activities
that resulted in operational challenges. The market is expected to reach $6.89
billion in 2025 at a CAGR of 28%.
The report covers the
remdesivir market segments-
1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets,
Frozen Solution, Lyophilized Solution
3) By Distribution Channel:
Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others
About The
Business Research Company:
The Business Research Company is a market
intelligence firm that excels in company, market, and consumer research.
Located globally it has specialist consultants in a wide range of industries
including manufacturing, healthcare, financial services, chemicals, and
technology. It has
offices in the UK, the US and India and a network of trained researchers in 20+
countries globally.
Contact
Information:
The Business Research Company
Europe: +44 207 1930 708
Asia:
+91 88972 63534
Americas:
+1 315 623 0293
Email: info@tbrc.info
Follow
us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow
us on Twitter: https://twitter.com/tbrc_info
Check
out our Blog: http://blog.tbrc.info/
No comments:
Post a Comment